NIH Extends Contract To BioHealth Innovation To Further Expand Entrepreneur-in-Residence Program Established In 2012

ROCKVILLE, Md., April 10, 2017 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland, has been awarded a renewal of its contract to extend and expand its entrepreneur-in-residence (EIR) program with the National Institutes of Health (NIH). BHI will place EIRs within the National Heart, Lung and Blood Institute (NHLBI), the NIH Office of the Director and other NIH Institutes and Centers.

The EIR program was established with NIH in 2012 with BHI's support. The program is set-up to achieve the mission of NIH by applying knowledge gained through discoveries to solutions for patients with unmet clinical needs. EIRs who participate in this program have prior experience maneuvering through multi-disciplinary technical challenges and the business and regulatory environment to deploy new healthcare solutions. 

Due to the program's initial success, the EIR program was expanded in 2015 to include NIH's associated offices and institutes. The new term extends for an 18-month period from February 2017 through August 2018, with an option to renew for an additional 18 months.

"Expanding and extending our partnership with the federal government's leading medical research agency is an honor that builds on our work together filling key EIR roles over the last few years," said Richard Bendis, BHI President and CEO. "We've placed some of the most innovative and business-centered minds in biohealth and biotech and will continue to do so as we fill EIR roles that will drive cutting-edge approaches to commercializing medical devices and therapies."

BHI can retain the services of up to six EIRs as a part of this program with NIH. The EIRs will be assigned to the appropriate facilities, and their task will be to foster collaboration between NIH leadership and the biohealth industry, while providing the agency with industry insights into innovation and commercialization perspectives in research and development. They will also help to guide NIH scientists, academics and small business innovators on best practices.

More information can be found at http://www.biohealthinnovation.org/programs/entrepreneur-in-residence-program.

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. BHI is known for providing commercial assistance to scientists and founders, educating and infusing Maryland's life science community with new and young entrepreneurs and fueling startups within Central Maryland's bio-ecosystem by connecting young companies to funding and business resources. Learn more at www.biohealthinnovation.org.

SOURCE BioHealth Innovation, Inc.

Related Links

http://www.biohealthinnovation.org